Home Cambridge rare disease biotech Synageva to be acquired for $8.4B
 

Keywords :   


Cambridge rare disease biotech Synageva to be acquired for $8.4B

2015-05-06 13:59:14| Biotech - Topix.net

Cambridge rare disease biotech Synageva BioPharma Corp. will be acquired for $8.4 billion by Connecticut-based Alexion Pharmaceuticals, the two companies announced today.

Tags: disease rare acquired cambridge

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11
27.11PSA10 SSP
27.11
27.11
27.11
27.115
27.11BTR 20()competition
27.11DVD
More »